A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

NCT00207688 · clinicaltrials.gov ↗

COMPLETED

Status

505

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Infliximab 5 mg/kg
DRUG: Infliximab 10 mg/kg
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC

Collaborators

[object Object]